A Multicenter, Real-world Study of Adebrelimab in the Treatment of Extensive Stage Small Cell Lung Cancer

Adebrelimab Plus Chemoradiotherapy Followed by Adebrelimab Maintenance in Limited-Stage SCLC

NCT07200154 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Adebrelimab + Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC

NCT07035392 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC

NCT06217757 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Assessment of Adebelizumab Combined with Chemotherapy in Concurrent Radiotherapy Versus Sequential Radiotherapy As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

NCT06768307 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Adebrelimab Maintenance Therapy After Concurrent Chemoradiotherapy with Hyperfractionated Radiotherapy in Limited-Stage Small Cell Lung Cancer

NCT06784206 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Evaluation of TRILACICLIB in Chinese Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC) for Chemotherapy-induced Myelosuppression, Antitumor Effects of Combination Regimens, and Safety in a Real-world Study

NCT05071703 ·Status: COMPLETED ·Phase: PHASE4

A Study of Concurrent Chemoradiation With Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

NCT04636762 ·Status: COMPLETED ·Phase: PHASE2

Neoadjuvant Treatment of Locally Advanced Hypopharyngeal Cancer With Adebrelimab Combined With TP Chemotherapy Regimen

NCT07137039 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

The Combination of Adebrelimab and TP Regimen for Neoadjuvant Therapy in Patients With Stage IVB Oral Squamous Cell Carcinoma

NCT06277791 ·Status: RECRUITING ·Phase: PHASE2

The Efficacy and Safety of Adjuvant Immunotherapy After Pathological Complete Response Following Neoadjuvant Chemoimmunotherapy in Patients with Resectable NSCLC

NCT06243679 ·Status: ACTIVE_NOT_RECRUITING

Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine Tumors

NCT06764368 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC

NCT07247227 ·Status: RECRUITING ·Phase: NA

A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC

NCT06424899 ·Status: RECRUITING ·Phase: PHASE2

Personalized Neoantigen MRNA Vaccine Combined with Adebrelimab in Non-Small Cell Lung Cancer Patients

NCT06685653 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

A Trial of SHR-1316 Maintenance Therapy for Limited Stage Small Cell Lung Cancer

NCT04647357 ·Status: UNKNOWN ·Phase: PHASE2

Real World Study of Efficacy and Safety of Atezolizumab Plus Chemotherapy in Chinese Patients With ES-SCLC

NCT04663438 ·Status: UNKNOWN

Efficacy and Safety of High-Dose Rate Brachytherapy with Immunotherapy and Chemotherapy As Second-Line Treatment for Advanced Non-Small Cell Lung Cancer

NCT06518018 ·Status: ACTIVE_NOT_RECRUITING

Chemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage Small-cell Lung Cancer

NCT06514118 ·Status: RECRUITING

Phase III Study of SHR-8068 Combined With Adebrelimab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer

NCT07170995 ·Status: RECRUITING ·Phase: PHASE3

A Trial of SHR1701 Combined With Radiotherapy for Metastatic Non-small Cell Lung Cancer Failure After First-line Treatment

NCT04560244 ·Status: UNKNOWN ·Phase: PHASE2

A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC Patients

NCT06335355 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

First-line Treatment for ES-SCLC with Chemotherapy Combined with PD-1/PD-L1 Inhibitor Sequential Thoracic Radiotherapy

NCT06586697 ·Status: RECRUITING ·Phase: PHASE2

Xingbai Ji Formula Combined with Chemotherapy and Sintilimab in Metastatic Multi-Target Mutation-Negative Non-Small Cell Lung Cancer: a Clinical Trial

NCT06848426 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Real-world Study of the Efficacy and Safety of PD-1 Inhibitors Combined With Chemoradiotherapy in Lung Metastatic Nasopharyngeal Carcinoma

NCT07062484 ·Status: NOT_YET_RECRUITING ·Phase: NA

The Efficacy and Safety of Radiotherapy Plus Niraparib and Toripalimab in Patients With Recurrent Small Cell Lung Cancer

NCT05162196 ·Status: UNKNOWN ·Phase: PHASE2